• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. OPTETRAK; CEMENTED FINNED TIB. TRA SZ 2F/1T

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. OPTETRAK; CEMENTED FINNED TIB. TRA SZ 2F/1T Back to Search Results
Model Number CEMENTED CR FEMORAL SZ 2
Medical Device Problem Code Loosening of Implant Not Related to Bone-Ingrowth (4002)
Health Effect - Clinical Codes Failure of Implant (1924); No Code Available (3191)
Date of Event 10/19/2011
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Additional information, including the product investigation, will be submitted within 30 days of receipt.
 
Event or Problem Description
As reported by (b)(6), this (b)(6) y/o, female patient underwent primary total prosthetic replacement using cement of the left knee via medial parapatellar approach on (b)(6) 2009.The indication for the index procedure was osteoarthritis.The patient was implanted with a optetrak knee system - cemented cruciate retained (cr) femoral component - size 2 (catalog 200-01-02, serial (b)(4)), optetrak knee system - cemented finned tibial tray - sizes 1f/1t 2f/1t(catalog 200-04-21, serial (b)(4)), optetrak knee system - cruciate retained (cr) tibial insert - size 2 - 13mm (catalog 200-22-13, serial (b)(4)), optetrak knee system - three pegs patella - diameter 32mm (catalog 200-02-32, serial (b)(4)) and heraeus medical antibiotic loaded high viscosity bone cement (catalog 66017569, serial (b)(4)).On (b)(6) 2011, approximately 22 months post implantation, the patient underwent revision due to aseptic loosening tibia.The exactech were removed and replaced.
 
Additional Manufacturer Narrative
Section h10: (h3) the evaluation noted that revision reported was likely the result of an insufficient bond between the implant and the bone, which led to aseptic (non-infected) loosening, possibly secondary to increased biomechanical stress.However, this cannot be confirmed since the devices were not returned for evaluation.This submission represents 1 of 163 events identified via active surveillance activities utilizing data form the united kingdom national joint registry (uknjr).Follow-ups for additional information cannot be performed for this complaint as the information was submitted as complete by the registry; there is no identification of facilities or surgeons.All available information about the event and/or patient has been provided and it is not possible to obtain any of the devices.No information provided in the following section(s): a4, a5, and b6, the following section(s) have additional info: a1, b5, d1, d2, d4 (exp date), e2, e4, g4, g7, h1, h2, h3, h4, h6, and h7.Section h11: corrections made in the following section(s): (a1) patient identifier has been updated.(d1) brand name.(d2) common device name.(d4) model number was entered in error.Please disregard.(h4) manufacture date.(h6) patient code was entered in error.This has been corrected in new submission.
 
Event or Problem Description
As reported by united kingdom national joint registry (uknjr), this 58 y/o, female patient underwent primary total prosthetic replacement using cement of the left knee via medial parapatellar approach on (b)(6) 2009.The indication for the index procedure was osteoarthritis.On (b)(6) 2011, approximately 22 months post implantation, the patient underwent revision due to aseptic loosening of the tibia.The follow-ups for additional information cannot be performed for this complaint, information was submitted as complete by the united kingdom national joint registry (uknjr); there is no identification of facilities or surgeons.All available information about the event and/or patient has been provided.These devices are used for treatment not diagnosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTETRAK
Common Device Name
CEMENTED FINNED TIB. TRA SZ 2F/1T
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
MDR Report Key9711531
Report Number1038671-2020-00172
Device Sequence Number16654244
Product Code JWH
UDI-Device Identifier10885862039521
UDI-Public10885862039521
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K932776
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2009
Device Explanted Year2011
Reporter Type Manufacturer
Report Source consumer,foreign,study
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 05/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/15/2014
Device Model NumberCEMENTED CR FEMORAL SZ 2
Device Catalogue Number200-04-21
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 01/15/2020
Supplement Date Received by Manufacturer05/04/2020
Initial Report FDA Received Date02/14/2020
Supplement Report FDA Received Date05/08/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age58 YR
-
-